Pozen Scores Win In Shareholder Suit Over Treximet

Law360, New York (October 1, 2009, 2:47 PM EDT) -- A federal court has dismissed a consolidated putative securities class action against Pozen Inc. over disclosures made while the pharmaceutical company was seeking approval from the U.S. Food and Drug Administration for migraine treatment Treximet.

In a ruling issued Tuesday, Judge N. Carlton Tilley of the U.S. District Court for the Middle District of North Carolina agreed with a magistrate judge's recommendations that the case be dismissed, overriding the plaintiffs' subsequent objections.

Judge Tilley also denied an alternative request by the plaintiffs to further redraft their...
To view the full article, register now.